Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Mahfoud

Showing results (591-600 of 614) with videos related to

Pageof 62
Sort By:
Journal of the American College of Cardiology|January 19, 2026
Cardiovascular Risk Across Myocardial Injury and Infarction Categories Using the Universal Definition: An Individual Patient-Level Data Meta-AnalysisJasper Boeddinghaus, Pedro Lopez-Ayala, Alexander J F Thurston, et al.
European Heart Journal|May 21, 2015
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial designFelix Mahfoud, Michael Böhm, Michel Azizi, et al.
Communications Medicine|January 27, 2026
Ischemic brain infarcts, white matter hyperintensities, and cognitive impairment are increased in patients with Atrial FibrillationPhilipp Krisai, Stefanie Aeschbacher, Michael Coslovsky, et al.
American Heart Journal|November 2, 2025
PRospective evaluation of the European Society of Cardiology 0/1h-algorithm`s safety and efficacy for triage of patients with suspected myocardial infarction (PRESC1SE-MI): Rationale and design of a prospective international multicenter stepped-wedge cluster randomized controlled trialJasper Boeddinghaus, Paolo Bima, Luca Crisanti, et al.
Journal of the American College of Cardiology|March 25, 2026
High-Sensitivity Cardiac Troponin T-gen6 Assay in Suspected Myocardial Infarction: Diagnostic Accuracy, Cutoffs, and Clinical ImplicationsLuca Koechlin, Pedro Lopez-Ayala, Alexander J F Thurston, et al.
The New England Journal of Medicine|August 27, 2021
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Enrico Frigoli, Dik Heg, et al.
Journal of the American College of Cardiology|November 1, 2023
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E Kandzari, Raymond R Townsend, Kazuomi Kario, et al.
Journal of the American College of Cardiology|September 12, 2013
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertensionMarkus P Schlaich, Roland E Schmieder, George Bakris, et al.
Lancet (London, England)|May 19, 2021
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trialMichel Azizi, Kintur Sanghvi, Manish Saxena, et al.
European Heart Journal|March 27, 2020
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapiesFelix Mahfoud, Michel Azizi, Sebastian Ewen, et al.
Pageof 62

Showing results (591-600 of 614) with videos related to

Sort By:
Pageof 62
Journal of the American College of Cardiology|January 19, 2026
Cardiovascular Risk Across Myocardial Injury and Infarction Categories Using the Universal Definition: An Individual Patient-Level Data Meta-AnalysisJasper Boeddinghaus, Pedro Lopez-Ayala, Alexander J F Thurston, et al.
European Heart Journal|May 21, 2015
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial designFelix Mahfoud, Michael Böhm, Michel Azizi, et al.
Communications Medicine|January 27, 2026
Ischemic brain infarcts, white matter hyperintensities, and cognitive impairment are increased in patients with Atrial FibrillationPhilipp Krisai, Stefanie Aeschbacher, Michael Coslovsky, et al.
American Heart Journal|November 2, 2025
PRospective evaluation of the European Society of Cardiology 0/1h-algorithm`s safety and efficacy for triage of patients with suspected myocardial infarction (PRESC1SE-MI): Rationale and design of a prospective international multicenter stepped-wedge cluster randomized controlled trialJasper Boeddinghaus, Paolo Bima, Luca Crisanti, et al.
Journal of the American College of Cardiology|March 25, 2026
High-Sensitivity Cardiac Troponin T-gen6 Assay in Suspected Myocardial Infarction: Diagnostic Accuracy, Cutoffs, and Clinical ImplicationsLuca Koechlin, Pedro Lopez-Ayala, Alexander J F Thurston, et al.
The New England Journal of Medicine|August 27, 2021
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Enrico Frigoli, Dik Heg, et al.
Journal of the American College of Cardiology|November 1, 2023
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E Kandzari, Raymond R Townsend, Kazuomi Kario, et al.
Journal of the American College of Cardiology|September 12, 2013
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertensionMarkus P Schlaich, Roland E Schmieder, George Bakris, et al.
Lancet (London, England)|May 19, 2021
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trialMichel Azizi, Kintur Sanghvi, Manish Saxena, et al.
European Heart Journal|March 27, 2020
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapiesFelix Mahfoud, Michel Azizi, Sebastian Ewen, et al.
Pageof 62